A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

He discusses how Exscientia’s approach has evolved from a singular focus to an end-to-end process for improving drug design and development with AI. Hopkins and host Jonah Comstock also get into ...

His team harnesses advanced computational technologies, including AI, with the aim of enhancing the discovery, design, optimization and synthesis of small molecules to be developed into innovative ...

After offering a deep dive last year into the recipe behind its lead lung fibrosis candidate, Insilico Medicine is now giving ...

These considerations will be valuable to sponsors (i.e., of clinical investigations, such as Investigational New Drug Exemption applications), along with AI model developers and other firms in the ...

Combining quantum physics, computational chemistry, and AI, XtalPi empowers scientists to efficiently explore areas for the design and ... by existing drug patents. “AWS’s flexible, secure ...

Honda is also tapping into AWS generative AI services, specifically Amazon Bedrock. For example, it’s developing a new system that guides drivers to the best charging stations based on location ...

HERE has been utilizing AWS for its core cloud infrastructure, data platform and AI/ML model deployment for nearly a decade. This expanded collaboration allows HERE to offer automakers a comprehensive ...

Andy Jassy, president and CEO of Amazon, described the final quarter of 2024 as being one of “remarkable innovation” for AWS, following the roll-out of new artificial intelligence (AI ...